Mark M. Perry

2.8k total citations
26 papers, 2.2k citations indexed

About

Mark M. Perry is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Mark M. Perry has authored 26 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 6 papers in Physiology. Recurrent topics in Mark M. Perry's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (5 papers). Mark M. Perry is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (5 papers). Mark M. Perry collaborates with scholars based in United Kingdom, United States and Netherlands. Mark M. Perry's co-authors include Mark A. Lindsay, Andrew E. Williams, Sterghios Moschos, Hanna Larner-Svensson, Kian Fan Chung, Ian M. Adcock, Peter J. Barnes, Eleni Tsitsiou, Jonas S. Erjefält and Maria G. Belvisi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark M. Perry

26 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark M. Perry United Kingdom 18 1.4k 1.3k 435 285 282 26 2.2k
Michael Karbiener Austria 22 985 0.7× 846 0.7× 118 0.3× 443 1.6× 105 0.4× 56 1.8k
Marah C. Runtsch United States 14 1.4k 1.0× 854 0.7× 707 1.6× 115 0.4× 84 0.3× 22 2.1k
Zhaoyu Lin China 27 2.0k 1.4× 1.1k 0.9× 478 1.1× 118 0.4× 280 1.0× 88 2.9k
Liantang Wang China 28 1.2k 0.9× 695 0.5× 565 1.3× 76 0.3× 218 0.8× 68 2.3k
A.E. Greijer Netherlands 8 626 0.4× 589 0.5× 144 0.3× 115 0.4× 90 0.3× 10 1.2k
Dalila Lucíola Zanette Brazil 23 864 0.6× 570 0.4× 244 0.6× 91 0.3× 100 0.4× 86 1.7k
Henry S. Cheng United States 17 1.1k 0.8× 721 0.6× 343 0.8× 82 0.3× 59 0.2× 33 1.6k
Joanne Smith United Kingdom 7 527 0.4× 341 0.3× 705 1.6× 175 0.6× 81 0.3× 8 1.5k
Ya Zhou China 24 809 0.6× 677 0.5× 358 0.8× 91 0.3× 108 0.4× 75 1.4k
Wei Luo China 20 683 0.5× 264 0.2× 886 2.0× 250 0.9× 163 0.6× 62 1.8k

Countries citing papers authored by Mark M. Perry

Since Specialization
Citations

This map shows the geographic impact of Mark M. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Perry more than expected).

Fields of papers citing papers by Mark M. Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Perry. The network helps show where Mark M. Perry may publish in the future.

Co-authorship network of co-authors of Mark M. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Perry. A scholar is included among the top collaborators of Mark M. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Perry. Mark M. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pullen, Nick, Andrew R. Pickford, Mark M. Perry, et al.. (2018). Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary. Portsmouth Research Portal (University of Portsmouth). Volume 5. 13–30. 15 indexed citations
2.
Austin, Philip, Eleni Tsitsiou, Simon W. Jones, et al.. (2016). Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. Journal of Allergy and Clinical Immunology. 139(3). 780–789. 83 indexed citations
3.
Perry, Mark M., Andrew Durham, Philip Austin, Ian M. Adcock, & Kian Fan Chung. (2015). BET Bromodomains Regulate Transforming Growth Factor-β-induced Proliferation and Cytokine Release in Asthmatic Airway Smooth Muscle. Journal of Biological Chemistry. 290(14). 9111–9121. 42 indexed citations
4.
Perry, Mark M., Ian M. Adcock, & Kian Fan Chung. (2015). Role of microRNAs in allergic asthma. Current Opinion in Allergy and Clinical Immunology. 15(2). 156–162. 38 indexed citations
5.
Perry, Mark M., et al.. (2014). The anti-proliferative effect of hydrogen sulfide upon human airway smooth muscle in COPD. European Respiratory Journal. 44(Suppl 58). 3417–3417. 1 indexed citations
6.
Perry, Mark M., Eleni Tsitsiou, Philip Austin, et al.. (2014). Role of non-coding RNAs in maintaining primary airway smooth muscle cells. Respiratory Research. 15(1). 58–58. 58 indexed citations
7.
Chachi, Latifa, Christine R. Keenan, Mark M. Perry, et al.. (2014). Mechanisms of glucocorticoid action and insensitivity in airways disease. Pulmonary Pharmacology & Therapeutics. 29(2). 129–143. 52 indexed citations
8.
Adcock, Ian M., et al.. (2014). miRNA-145 & SMAD3 expression in patients with COPD. 44. 3342. 1 indexed citations
9.
Perry, Mark M., et al.. (2013). Airway Smooth Muscle Hyperproliferation Is Regulated by MicroRNA-221 in Severe Asthma. American Journal of Respiratory Cell and Molecular Biology. 50(1). 7–17. 123 indexed citations
10.
Perry, Mark M., et al.. (2011). Airway smooth muscle cells from patients with COPD exhibit a higher degree of cellular proliferation and steroid insensitivity than that from healthy patients. European Respiratory Journal. 38(Suppl 55). p748–p748. 5 indexed citations
11.
Perry, Mark M., Christopher Hui, Matthew Whiteman, et al.. (2011). Hydrogen Sulfide Inhibits Proliferation and Release of IL-8 from Human Airway Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology. 45(4). 746–752. 74 indexed citations
12.
Larner-Svensson, Hanna, Andrew E. Williams, Eleni Tsitsiou, et al.. (2010). Pharmacological studies of the mechanism and function of interleukin-1β-induced miRNA-146a expression in primary human airway smooth muscle. Respiratory Research. 11(1). 68–68. 68 indexed citations
13.
Perry, Mark M., Christopher Hui, Matthew Whiteman, et al.. (2010). Hydrogen Sulfide Inhibits Proliferation and Release of IL-8 from Human Airway Smooth Muscle Cells. Free Radical Biology and Medicine. 49. S52–S52. 1 indexed citations
14.
Perry, Mark M., Andrew E. Williams, Eleni Tsitsiou, Hanna Larner-Svensson, & Mark A. Lindsay. (2009). Divergent intracellular pathways regulate interleukin‐1β‐induced miR‐146a and miR‐146b expression and chemokine release in human alveolar epithelial cells. FEBS Letters. 583(20). 3349–3355. 97 indexed citations
15.
Williams, Andrew E., Hanna Larner-Svensson, Mark M. Perry, et al.. (2009). MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. PLoS ONE. 4(6). e5889–e5889. 155 indexed citations
16.
Perry, Mark M., et al.. (2008). Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells. The Journal of Immunology. 180(8). 5689–5698. 388 indexed citations
17.
Moschos, Sterghios, Simon W. Jones, Mark M. Perry, et al.. (2007). Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate Immunity. Bioconjugate Chemistry. 18(5). 1450–1459. 267 indexed citations
18.
Williams, Andrew E., Mark M. Perry, Sterghios Moschos, & Mark A. Lindsay. (2007). microRNA expression in the aging mouse lung. BMC Genomics. 8(1). 172–172. 72 indexed citations
19.
Moschos, Sterghios, Andrew E. Williams, Mark M. Perry, et al.. (2007). Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics. 8(1). 240–240. 244 indexed citations
20.
Williams, Andrew E., Sterghios Moschos, Mark M. Perry, Peter J. Barnes, & Mark A. Lindsay. (2006). Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Developmental Dynamics. 236(2). 572–580. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Karbiener Breakdown of academic impact, for papers by Marah C. Runtsch Breakdown of academic impact, for papers by Zhaoyu Lin Breakdown of academic impact, for papers by Liantang Wang Breakdown of academic impact, for papers by A.E. Greijer Breakdown of academic impact, for papers by Dalila Lucíola Zanette Breakdown of academic impact, for papers by Henry S. Cheng Breakdown of academic impact, for papers by Joanne Smith Breakdown of academic impact, for papers by Ya Zhou Breakdown of academic impact, for papers by Wei Luo
Rankless by CCL
2026